Eden Research plc (AIM:EDEN) announced today that Derek McAllan has stepped down from the Board with immediate effect due to ill health.
McAllan served as a non-executive director and chair of the Audit Committee at the biopesticide and biocontrol technology company. Rob Cridland will serve as interim chair of the Audit Committee until a replacement is appointed.
During his tenure, McAllan guided the company through regulatory approvals and capital raising activities.
Lykele van der Broek, Chairman of Eden Research, said: "On behalf of the Board and everyone at Eden Research, I would like to thank Derek for his dedication and contribution. His insight, professionalism and commitment have been greatly valued. We are naturally saddened that ill health has led to his retirement and we wish him a full recovery and all the very best for the future."
The company stated that no further disclosures are required pursuant to Schedule Two of the AIM Rules.
Eden Research develops biopesticide products and natural microencapsulation technologies for crop protection, animal health and consumer products industries.
